Keyron

London, United Kingdom Founded: 2006 • Age: 20 yrs
Therapeutics and diagnostic devices for diabetes and obesity are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Keyron

Keyron is a company based in London (United Kingdom) founded in 2006. Keyron offers products and services including ForePass®. Keyron operates in a competitive market with competitors including Fractyl, GI Windows, GI Dynamics, ValenTx and Hangzhou Tongee Medical Technology, among others.

  • Headquarter London, United Kingdom
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Keyron Ltd
  • Date of Incorporation 11 Aug, 2016
  • Jurisdiction EASTCOTE, PINNER, MIDDLESEX, ENGLAND
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Keyron

Keyron offers a comprehensive portfolio of products and services, including ForePass®.

Product name locked
Category locked
Primary

Non-surgical endoscopic procedure for reversing obesity and diabetes.

People of Keyron

Headcount 10-50
Employee Profiles 5
Board Members and Advisors 7
Employee Profiles
People
Jayme McGillis
Consulting COO
People
Giorgio Castagneto Gissey
CEO, Chairman, & Co-Founder
People
Eyal S. Ron
CTO
People
Marco Castagneto
CSO & Co-Founder

Unlock access to complete

Board Members and Advisors
people
Ricardo Cohen
Advisor
people
Nicolaas Verheem
Director
people
G. Mingrone
Advisor
people
P. Schauer
Advisor

Unlock access to complete

Funding Insights of Keyron

Premium access

Detailed funding history for Keyron

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Keyron

Investments
Premium access

Investment portfolio details for Keyron

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Keyron

Premium access

Detailed financials for Keyron

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Keyron Comparisons

Keyron Primary company
Description
Therapeutics and diagnostic devices for diabetes and obesity...
Location
London, United Kingdom
Founded Year
2006
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Keyron

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Keyron

Keyron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fractyl, GI Windows, GI Dynamics, ValenTx and Hangzhou Tongee Medical Technology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Endoscopic procedures for type-2 diabetes treatment are developed.
Locked Locked Locked
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
Locked Locked Locked
Endoscopic barriers for diabetes and metabolic disease treatment are developed.
Locked Locked Locked
Provides an adjustable endoluminal bypass sleeve for obesity treatment.
Locked Locked Locked
Medical technology solutions are developed in Hangzhou, China.
Locked Locked Locked
Endoscopically introduced bile diversion device
Premium access

Detailed competitors of Keyron

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Keyron

Premium access

Complete news archive for Keyron

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keyron

Keyron was founded in 2006.

Keyron is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Giorgio Castagneto is the current CEO of Keyron.

Keyron was founded in 2006 in London, United Kingdom, focusing on the biotechnology and medical device sectors. Therapeutics for type 2 diabetes are under development, with clinical trials ongoing. Endoscopically implantable devices for treating obesity and related conditions have been created. A medical device for diagnosing and measuring non-alcoholic fatty liver disease and insulin resistance has also been developed.

Keyron's top competitors include Fractyl, GI Windows and GI Dynamics.

Keyron offers ForePass®.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available